Showing results (901-910 of 1,279) with videos related to

Sort By:
Pageof 128
Annals of the Rheumatic Diseases|July 17, 2001
Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalphaD Baeten, N Van Damme, F Van den Bosch, et al.
International Journal of Immunogenetics|May 17, 2007
CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's diseaseH Peeters, S Bogaert, D Laukens, et al.
AIDS (London, England)|January 1, 1992
Antibodies and complement enhance binding and uptake of HIV-1 by human monocytesL J Bakker, H S Nottet, N M de Vos, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|September 9, 2009
Neonatal seizure localization using PARAFAC decompositionW Deburchgraeve, P J Cherian, M De Vos, et al.
Methods of Information in Medicine|November 27, 2014
Motor Unit Tracking Using High Density Surface Electromyography (HDsEMG) . Automated Correction of Electrode Displacement ErrorsI Gligorijević, B T H M Sleutjes, M De Vos, et al.
Journal of Applied Toxicology : JAT|June 29, 2021
Toxicological safety evaluation of live Anaerobutyricum soehngenii strain CH106Jos F M L Seegers, Ismail Sahin Gül, Stijn Hofkens, et al.
Ebiomedicine|June 5, 2024
Human milk oligosaccharide composition is affected by season and parity and associates with infant gut microbiota in a birth mode dependent manner in a Finnish birth cohortDollwin Matharu, Alise J Ponsero, Marton Lengyel, et al.
Immunogenetics|March 6, 2007
MHC class I A region diversity and polymorphism in macaque speciesNel Otting, Annemiek J M de Vos-Rouweler, Corrine M C Heijmans, et al.
Gut Microbes|November 2, 2022
Unique Pakistani gut microbiota highlights population-specific microbiota signatures of type 2 diabetes mellitusAfshan Saleem, Aamer Ikram, Evgenia Dikareva, et al.
Inflammatory Bowel Diseases|August 30, 2022
Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel DiseaseMiikka Höyhtyä, Katri Korpela, Schahzad Saqib, et al.
Pageof 128